Listed

Adaptimmune Therapeutics PLC

ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31

Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adaptimmune Therapeutics PLC, Reports and events
FiledFormWhat it isAccession number
2023-11-0816:05 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-018265
2023-11-0807:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-018123
2023-11-0316:15 ET8-K5.02 Departure or appointment of officers or directors0001558370-23-017596
2023-10-3108:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-017061
2023-08-3117:19 ET8-K3.01 Delisting notice0001558370-23-015390
2023-08-1016:05 ET8-K/A9.01 Financial statements and exhibits0001558370-23-014493
2023-08-0916:06 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-014250
2023-08-0907:42 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-014085
2023-06-2916:25 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-23-076342
2023-06-0116:09 ET8-K2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-067030
2023-05-3016:18 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-23-066048
2023-05-2206:59 ET8-K8.01 Other events0001104659-23-062908
2023-05-1607:35 ET8-K5.07 Shareholder vote results0001104659-23-061177
2023-05-1216:05 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-009595
2023-05-1207:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-009504
2023-04-1308:00 ETDEF 14AProxy statement0001104659-23-044825
2023-04-1108:08 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-005713
2023-03-3017:13 ETSC 13D/AOwnership report, active investor, amended0001072613-23-000276
2023-03-1016:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-003489
2023-03-0616:07 ET10-KAnnual reportPeriod 2022-12-310001558370-23-002907
2023-03-0606:47 ET8-K1.02 Termination of a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-23-002829
2023-03-0606:34 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-028734
2023-02-1608:14 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-001414
2023-01-3116:15 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001558370-23-000722
2022-12-2016:05 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-22-018828
2022-11-0816:14 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016869
2022-11-0807:42 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-016748
2022-11-0807:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-016746
2022-10-2508:10 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001558370-22-015279
2022-09-0907:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-014297
2022-08-0416:06 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-012182
2022-08-0407:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-012058
2022-06-1516:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-22-010042
2022-05-2506:42 ET8-K5.07 Shareholder vote results0001104659-22-064428
2022-05-0916:06 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-007810
2022-05-0907:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-007708
2022-05-0408:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-22-006948
2022-04-2108:00 ETDEF 14AProxy statementPeriod 2022-05-250001104659-22-048084
2022-03-1408:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-003492
2022-03-1407:16 ET10-KAnnual reportPeriod 2021-12-310001558370-22-003489
2022-01-2608:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-007650
2021-11-1206:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-21-015611
2021-11-0416:11 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-014594
2021-11-0407:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-014450
2021-09-1307:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-012408
2021-09-0707:08 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-012236
2021-08-2016:31 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-21-011988
2021-08-1316:33 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-21-011688
2021-08-0916:20 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-010980
2021-08-0916:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-010969

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.